Clinical

Dataset Information

A Trial of JX-594 in Refractory Colorectal Carcinoma


ABSTRACT: The purpose of this study is to: * determine the maximally-tolerated dose (MTD) and/or maximum-feasible dose (MFD) of JX-594 administered by biweekly intravenous (IV) infusion. * determine the safety of JX-594(TK- GM-CSF+ Wyeth strain vaccinia) administered by biweekly IV infusion.

DISEASE(S): Colorectal Carcinoma,Carcinoma,Colorectal Neoplasms

PROVIDER: 2115509 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR